— Okta shares surged 12.4% after the access management company topped analysts' second-quarter earnings expectation and issued a strong full-year outlook. The company reported adjusted earnings of 31 cents per share, excluding items, on revenues totaling $556 million.
That came in ahead of the earnings per share of 22 cents and $535 million in revenue expected by analysts polled by Refinitiv.— The discount retail stock slumped 4.8% on disappointing third-quarter guidance. For the current period, Five Below said it expects revenues to range between $715 million and $730 million, versus the $738 million expected by analysts polled by StreetAccount. Earnings per share estimates also came in below expectations.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stocks making the biggest moves after hours: Salesforce, Okta, CrowdStrike, Five Below and moreThese are the stocks posting the largest moves in extended trading.
Source: NBCNewYork - 🏆 270. / 63 Read more »
These Stocks Are Moving the Most Today: Salesforce, Okta, UBS, CrowdStrike, Chewy, and MoreSalesforce issues an outlook for the third quarter and fiscal year better than analysts' forecasts, Okta raises its fiscal-year outlook, and UBS reports a...
Source: MarketWatch - 🏆 3. / 97 Read more »
These Stocks Are Moving the Most Today: Salesforce, Okta, UBS, Chewy, Palantir, CrowdStrike, and MoreSalesforce issues an outlook for the third quarter and fiscal year better than analysts' forecasts, Okta raises its fiscal-year outlook, and UBS reports a...
Source: MarketWatch - 🏆 3. / 97 Read more »
Stocks making the biggest premarket moves: Dollar General, Salesforce, Palantir and moreThese are the stocks posting the largest moves in the premarket.
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »
Tilray and Curaleaf Stocks Surge as DEA Considers Reclassifying MarijuanaThe Drug Enforcement Agency said it is considering reclassifying weed as a Schedule 3 drug, rather than as a Schedule 1 substance.
Source: MarketWatch - 🏆 3. / 97 Read more »